Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's Disease [Phase 4]
A Phase 4 open-label study assessing caregiver preference, safety, and tolerability of the rivastigmine transdermal patch (Exelon Patch) in …
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: An Open-label Extension to Evaluate the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease [Phase 3]
An open-label extension study evaluated the long-term efficacy and safety of the rivastigmine transdermal patch in patients with probable Al…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Study Evaluating The Safety Of AAB-003 (PF-05236812) In Subjects With Alzheimer's Disease [Phase 1]
Phase 1 safety study update of AAB-003 (PF-05236812) in Alzheimer's disease. Results have been posted following completion of the study.
-
FDA approval · 2017-02-22FDA Approved: VIZAMYL — Supplemental Application (GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare))
FDA approved a supplemental application for Vizamyl (flutemetamol F-18) submitted by GE Healthcare Inc. The action updates the regulatory st…
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: Effect of Therapeutic Light on Sleep, Circadian Rhythm, and Global Function in Women With Alzheimer's [NA]
This entry reports the completion of a clinical trial evaluating the effect of therapeutic light on sleep, circadian rhythm, and global func…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: Advance Planning for Home Services for Seniors [NA]
The clinical trial update reports results of an advance planning program for home services for seniors, including individuals with Alzheimer…
-
FDA approval · 2017-02-13FDA Approved: RIVASTIGMINE TARTRATE — Original Application (Nivagen Pharmaceuticals, Inc.)
The FDA approved the original application for rivastigmine tartrate from Nivagen Pharmaceuticals, Inc., establishing a generic version of ri…
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: 16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease Patients [Phase 4]
A Phase 4 interventional study evaluating titration and dose/efficacy of Exelon (rivastigmine) in Chinese patients with Alzheimer's disease …
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: A Non-drug Methods Study in Participants With Alzheimer's Disease [Phase 1]
Phase 1 trial update of non-drug methods in participants with Alzheimer's disease; the study is completed and results were posted.
-
CLINICAL_TRIALS research · 2017-02-03Clinical Trial Update: Phase 1 Study Investigating Effects of HTL0009936 on Cognition and BOLD fMRI Signals in Healthy Elderly Subjects [Phase 1]
Phase 1 study of HTL0009936 evaluating cognition and BOLD fMRI signals in healthy elderly subjects. Sponsor: Nxera Pharma UK Limited; the st…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Isotopic Imaging for Prodromal Alzheimer's Disease
This clinical trial update reports that a study on isotopic imaging for prodromal Alzheimer's disease has completed, sponsored by Centre Hos…
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: The Alzheimer's Disease THErapy With NEuroaid (ATHENE) Study [Phase 2]
Phase 2 study of NEuroaid for Alzheimer's disease sponsored by National University Hospital, Singapore; current status is unknown.
-
CLINICAL_TRIALS research · 2017-01-31Clinical Trial Update: Effects of Chromium on Insulin Resistance in Alzheimer Disease Patients [NA]
This document reports a clinical trial update on the effects of chromium on insulin resistance in Alzheimer disease patients. The status of …
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: Magnesium Sulfate for the Improvement of Cognition in Patients With Alzheimer Disease [NA]
This clinical trial update concerns magnesium sulfate as a potential cognitive treatment for Alzheimer's disease, sponsored by Metabolic The…
-
CLINICAL_TRIALS trial_result · 2017-01-30Clinical Trial Update: Impact of Physical Activity on Successful Aging [NA]
A completed clinical trial from Universita di Verona evaluated how physical activity affects aging-related outcomes in individuals with Alzh…
-
FDA approval · 2017-01-27FDA Approved: MEMANTINE AND DONEPEZIL HYDROCHLORIDES EXTENDED-RELEASE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal's generic memantine and donepezil hydrochlorides extended-release combination for the treatment of Alzheimer's disease.
-
CLINICAL_TRIALS research · 2017-01-25Clinical Trial Update: Orientation in AD Patients: PET-MR Study
This document provides a clinical trial update for a PET-MR study on orientation in patients with Alzheimer’s disease and mild cognitive imp…
-
CLINICAL_TRIALS trial_result · 2017-01-25Clinical Trial Update: Safety Study of Nicotinamide to Treat Alzheimer's Disease [Phase 1, Phase 2]
This clinical trial update reports a completed Phase 1/Phase 2 safety study of nicotinamide for Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: BPN14770 Single Ascending Dose Study in Healthy Male and Female Subjects [Phase 1]
Phase 1 single ascending dose study of BPN14770 in healthy adult participants completed, focusing on safety, tolerability, and pharmacokinet…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: A Multiple Ascending Dose Study of BPN14770 in Healthy Young and Elderly Male or Female Subjects [Phase 1]
Phase 1 multiple ascending dose study of BPN-14770 in healthy young and elderly adults; the study is completed. Alzheimer's disease is liste…
-
CLINICAL_TRIALS research · 2017-01-18Clinical Trial Update: ABILITY - TelerehABILITation: TechnologY-enhanced Multi-domain at Home Continuum of Care Program [NA]
Update on the ABILITY Telerehabilitation trial (NCT02746484) shows the study evaluating a technology-enhanced, home-based multi-domain rehab…
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Absolute Bioavailability of a Single, Fixed Subcutaneous Dose of Aducanumab in Healthy Participants [Phase 1]
Biogen completed a Phase 1 study to determine the absolute bioavailability of a single fixed subcutaneous dose of aducanumab in healthy part…
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Development of NIC5-15 in the Treatment of Alzheimer's Disease [Phase 2]
A Phase 2 trial of NIC5-15 for Alzheimer's disease has completed, with results posted in January 2017.
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions [Phase 1]
Phase 1 PET imaging study of an mGluR5 tracer across several neuropsychiatric conditions has been completed.
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: Behavioral and Neuroimaging Changes After Cognitive Rehab in Traumatic Brain Injuries (TBI) and Mild Cognitive Impairment (MCI) [Phase 1]
Phase 1 clinical trial evaluating the effects of cognitive rehabilitation on behavioral and neuroimaging outcomes in individuals with trauma…